Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 33.750
- -0.340-1.00%
Close Jan 8 16:00 ET
- 33.810
- +0.060+0.18%
Post 20:01 ET
68.86BMarket Cap22.59P/E (TTM)
33.920High33.395Low2.71MVolume33.710Open34.090Pre Close91.42MTurnover0.14%Turnover Ratio11.44P/E (Static)2.04BShares44.86352wk High3.99P/B66.67BFloat Cap32.82552wk Low1.61Dividend TTM1.98BShs Float44.863Historical High4.76%Div YieldTTM1.54%Amplitude6.376Historical Low33.741Avg Price1Lot Size
GlaxoSmithKline News
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
Update: Market Chatter: GSK Reportedly in Advanced Talks to Buy US Biotech IDRx
FDA Label Warning Threatens GSK's RSV Vaccine Sales -- Market Talk
Sector Update: Health Care Stocks Higher in Afternoon Trading
Sector Update: Health Care
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Top Midday Stories: Meta Platforms to Test EBay Listings on Facebook Marketplace; Quantum Computing Stocks Fall After Nvidia CEO's Comments
Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com
Update: Market Chatter: GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion
GSK Nearing $1 Billion Deal to Acquire US Biotech IDRx, FT Reports
Express News | 'GSK Nears $1bn Deal for Biotech Developing Drug for Rare Tumour' - Financial Times
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
The FDA states that GlaxoSmithKline (GSK.US) and Pfizer (PFE.US) RSV vaccines must include warnings about the rare risk of paralysis.
The FDA stated that a vaccine produced by GlaxoSmithKline (GSK.US) and Pfizer (PFE.US) must include a warning about the potential increased risk of a rare neurological side effect.
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death -- Barrons.com
GSK's Bone Cancer Treatment Receives Breakthrough Designation From US FDA
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
